Loading...
Bharat Parenterals Limited — Dolutegravir Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #13 for Dolutegravir · $1.4M export value · DGFT Verified
Bharat Parenterals Limited is the #13 Indian exporter of Dolutegravir with $1.4M in export value and 28 verified shipments. Bharat Parenterals Limited holds a 0.0% market share in Dolutegravir exports across 1 countries. The company exports 10 pharmaceutical products worth $5.2M across 8 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $20.4M | 409 | 25.3% |
| ZIMBABWE | $13.3M | 267 | 16.5% |
| KENYA | $10.3M | 205 | 12.7% |
| ETHIOPIA | $8.0M | 159 | 9.8% |
| MOZAMBIQUE | $6.8M | 137 | 8.5% |
| NIGERIA | $5.5M | 110 | 6.8% |
| TANZANIA | $3.6M | 73 | 4.5% |
| MYANMAR | $3.4M | 68 | 4.2% |
| BOTSWANA | $3.0M | 59 | 3.6% |
| TOGO | $1.7M | 34 | 2.1% |
India exports Dolutegravir to 145 countries. The top destination is SOUTH AFRICA (25.3%), followed by ZIMBABWE and KENYA.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NATIONAL MEDICAL STORES | KENYA | $4.8M | 97 |
| EMCURE PHARMACEUTICALS SA (PTY) LTD | SOUTH AFRICA | $4.1M | 82 |
| MINISTRY OF HEALTH AND CHILD CARE | ZIMBABWE | $4.0M | 81 |
| MINISTRY OF HEALTH | BHUTAN | $3.0M | 59 |
| UNITED NATIONS DEVELOPMENT PROGRAMM |
India exported $144.2M worth of Dolutegravir through 3,325 shipments from 104 suppliers to 145 countries, serving 592 buyers globally. Bharat Parenterals Limited contributes $1.4M to this total, accounting for 0.0% of India's Dolutegravir exports.
Bharat Parenterals Limited's average Dolutegravir shipment value is $50.0K per consignment, based on 28 shipments totaling $1.4M.
Bharat Parenterals Limited ranks #13 among 104 Indian Dolutegravir exporters with a 0.0% market share. The top 3 exporters are CIPLA LIMITED ($47.5M), HETERO LABS LIMITED ($35.5M), EMCURE PHARMACEUTICALS LIMITED ($19.4M). Bharat Parenterals Limited processed 28 shipments to 1 destination countries.
What Bharat Parenterals Limited must comply with to export Dolutegravir to its top destination countries
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | APL HEALTHCARE LIMITED | $2.5M | 51 | 9 | $50.0K |
| 5 | STRIDES PHARMA SCIENCE LIMITED | $1.9M | 39 | 12 | $50.0K |
| 13 | BHARAT PARENTERALS LIMITED ★ | $1.4M | 28 | 1 | $50.0K |
| 9 | LAURUS LABS LIMITED | $1.4M | 27 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 610 | 18.3% |
| NHAVA SHEVA SEA (INNSA1) | 465 | 14.0% |
| JNPT/ NHAVA SHEVA SEA | 316 | 9.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 284 | 8.5% |
| JNPT | 180 | 5.4% |
| HYDERABAD ACC (INHYD4) | 164 | 4.9% |
| HYDERABAD AIR | 147 | 4.4% |
| DELHI AIR | 137 | 4.1% |
Bharat Parenterals Limited also exports these antiviral & hiv medications products. Each links to the detailed product page.
Bharat Parenterals Limited exports 10 products worth $5.2M. Beyond Dolutegravir, top products include Tenofovir, Erythromycin, Acetylsalicylic, Salicylic, Lactulose. View the complete Bharat Parenterals Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Dolutegravir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Bharat Parenterals Limited's Dolutegravir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Bharat Parenterals Limited
Full Company Profile →
10 products · $5.2M total trade · 8 categories
| PAKISTAN |
| $1.6M |
| 31 |
| AFRICURE PHARMACEUTICALS BOTSWANA | BOTSWANA | $850.0K | 17 |
| CENAME ON BEHALF OF THE MINISTRY | CAMEROON | $550.0K | 11 |
| MINISTERIO DA SAUDE | MOZAMBIQUE | $200.0K | 4 |
| AFRICURE PHARMACEUTICALS BOTSWANA(P | BOTSWANA | $100.0K | 2 |
| MINISTERE DE SANTE PUBLIQUE SG/MSP | NIGER | $100.0K | 2 |
India's Dolutegravir is purchased by 592 buyers worldwide. The top buyer is NATIONAL MEDICAL STORES (KENYA), followed by EMCURE PHARMACEUTICALS SA (PTY) LTD and MINISTRY OF HEALTH AND CHILD CARE.
| 14 |
| $50.0K |
| 10 | LAURUS LABS PRIVATE LIMITED | $900.0K | 18 | 11 | $50.0K |
Bharat Parenterals Limited ranks #13 among 104 Indian Dolutegravir exporters. Average shipment value of $50.0K compared to the market average of $1.4M. The closest competitors by value are APL HEALTHCARE LIMITED and STRIDES PHARMA SCIENCE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 145+ countries, 592+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Bharat Parenterals Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Dolutegravir. For current shipment-level data, contact TransData Nexus.